Thursday 3rd December 2020: 14:00 GMT
ELRIG is delighted to partner with Alderley Park, as they showcase the newly launched Alderley Park Oncology Development Programme in the latest of our Hot Topic Webinar series, scheduled for 3rd December.
The national Alderley Park Oncology Development Programme, funded by Cancer Research UK and Innovate UK is designed to develop and progress start-up oncology projects by bringing together global pharmaceutical and healthcare companies, research institutions and public bodies to identify and progress exciting oncology innovations that will improve the diagnosis and treatment of cancer.
In our joint Hot Topic webinar, we will hear from 3 speakers on how the programme will work and the value it can deliver to researchers thinking about commercialising their work.
Jane Theaker (Kinomica)
‘The Kinomica story: a proteomic-data science and diagnostics company specialising in cell signalling’
Ned Wakeman and George Orphanides (Alderley Park)
‘The Alderley Park Oncology Development Programme: A national programme to identify, develop and progress commercially, exciting innovations that will improve the diagnosis and treatment of cancer’
Graeme Wilkinson (Medicines Discovery Catapult)
‘The Medicines Discovery Catapult: Reshaping medicines discovery in the UK’